Unicontin-E

Product Overview

Unicontin-E is a controlled-release tablet containing 400mg of Theophylline, designed for sustained relief of respiratory conditions including asthma, chronic bronchitis, and emphysema. This medication acts by relaxing airway muscles, facilitating easier breathing and alleviating symptoms of respiratory disorders.

Indications

This medication is indicated for:
– Management and prevention of chronic respiratory conditions
– Symptom relief including wheezing, dyspnea, and chest tightness
– Prevention of nocturnal symptoms
– Reduction of exacerbation frequency in chronic respiratory diseases

Administration

Take Unicontin-E tablets:
– Orally with a full glass of water
– Preferably with meals to reduce GI discomfort
– Swallow whole – do not crush, chew, or break
– Maintain regular dosing schedule as prescribed
– Never exceed recommended dosage

Mechanism of Action

Theophylline, the active component:
– Classified as a bronchodilator
– Relaxes bronchial smooth muscle
– Dilates airways to improve pulmonary airflow
– Exhibits anti-inflammatory properties
– Reduces airway inflammation and mucus production

Dosage Guidelines

Dosage is individualized based on:
– Patient age and weight
– Disease severity
– Therapeutic response
– Serum theophylline levels
Special considerations required for:
– Hepatic/renal impairment
– Concomitant medication use

Therapeutic Benefits

• Sustained symptom control for chronic respiratory conditions
• Improved pulmonary airflow and respiratory function
• Reduced nocturnal symptoms and exacerbations
• Effective maintenance therapy
• Convenient once/twice-daily dosing regimen

Adverse Effects

Common reactions may include:
– Gastrointestinal disturbances (nausea, vomiting)
– Neurological effects (headache, dizziness)
– Sleep disturbances (insomnia)
Most side effects are transient and dose-dependent

Precautions

Exercise caution if you have:
– Cardiovascular history
– Seizure disorders
– GI conditions
Avoid activities requiring alertness if experiencing dizziness
Limit caffeine intake during therapy

Storage Conditions

Maintain tablets:
– At controlled room temperature (20-25°C)
– In original, tightly sealed container
– Protected from moisture and heat
– Out of children’s reach
– Discard after expiration date

Medical Disclaimer

This information is provided for educational purposes only and does not constitute medical advice. While we strive for accuracy, this content should not replace professional medical consultation. Always consult your healthcare provider regarding:
– Potential drug interactions
– Complete safety information
– Individual treatment plans
This resource is intended to complement, not substitute, the physician-patient relationship.